Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
14.4M
-
Shares change
-
+874K
-
Total reported value, excl. options
-
$12.8M
-
Value change
-
+$798K
-
Number of buys
-
17
-
Number of sells
-
-12
-
Price
-
$0.89
Significant Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q3 2025
41 filings reported holding NMTC - NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share as of Q3 2025.
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.4M shares
of 50M outstanding shares and own 28.81% of the company stock.
Largest 10 shareholders include Bleichroeder LP (4M shares), Sio Capital Management, LLC (2.36M shares), BARD ASSOCIATES INC (1.85M shares), VANGUARD GROUP INC (1.58M shares), PERKINS CAPITAL MANAGEMENT INC (1.47M shares), AWM Investment Company, Inc. (917K shares), RENAISSANCE TECHNOLOGIES LLC (693K shares), GEODE CAPITAL MANAGEMENT, LLC (497K shares), CITADEL ADVISORS LLC (206K shares), and Cambridge Investment Research Advisors, Inc. (121K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.